Results 131 to 140 of about 6,174 (184)

Combination of the Novel RAF Dimer Inhibitor Brimarafenib With the MEK Inhibitor Mirdametinib Is Effective Against NRAS Mutant Melanoma. [PDF]

Pigment Cell Melanoma Res
Tellenbach FL, Seiler L, Johnson M, Rehrauer H, Schukla P, Martinez-Gomez J, Stoffel CI, Kamal A, Dummer R, Levesque MP, Eichhoff OM.   +10 more
europepmc   +1 more source

Personalized therapies in advanced BRAFV600-mutated melanoma: review based on 3 case reports of the REMINISCENCE project. [PDF]

Melanoma Manag
Gebhardt C, Debus D, Rohrer P, Kähler KC, Koch L, Terheyden P, Nguyen VA.   +6 more
europepmc   +1 more source

A plain language summary of POLARIS: a study to look at different doses of encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis. [PDF]

Future Oncol
Menzies AM, Long GV, Kohn A, Tawbi H, Webe J, Flaherty K, McArthur GA, Ascierto PA, Pfluger Y, Lewis K, Tsai KK, Hamid O, Prenen H, Fein L, Wang E, Guenzel C, Zhang F, Kleh JF, di Pietro A, Davies MA.   +19 more
europepmc   +1 more source

Successful Treatment of BRAF V600E-Mutant Intrahepatic Cholangiocarcinoma With Encorafenib, Binimetinib, and Cetuximab. [PDF]

Cureus
Yamaguchi T, Hirose Y, Nakazawa Y, Kagotani A, Kodama H, Yukami H, Kameishi S, Matsuo N, Fakhrejahani E, Nishikawa H.   +9 more
europepmc   +1 more source

Preventive strategies against brain metastases: current state of the art and future directions. [PDF]

Neurol Res Pract
Ippen FM, Konen FF, Hau P, Winkler F.
europepmc   +1 more source

Noninvasive Therapeutic Monitoring of Circulating Tumor DNA in BRAF-Mutant Metastatic Colon Cancer Using Droplet Digital PCR, Next-Generation Sequencing, and Fragmentomics. [PDF]

Case Rep Oncol Med
Lam RCT, Hui CWC, Tse IOL, Zhou Q, Chow C, Kang W, Chan KCA, Ma BBY, Lam WKJ.   +8 more
europepmc   +1 more source

Transoral videolaryngoscopic surgery for hypopharyngeal anaplastic metastasis from papillary thyroid carcinoma. [PDF]

JCEM Case Rep
Yokoyama Y, Nishio N, Sugiura M, Suzuki K, Wada A, Sone M.   +5 more
europepmc   +1 more source

Encorafenib/Binimetinib Regimen [PDF]

, 2020
openaire   +1 more source

Dissecting the MAPK signaling landscape in malignant melanoma: from BRAF and NRAS mutations to precision combination therapies. [PDF]

Front Cell Dev Biol
Fang X, Wang S, Fu S.
europepmc   +1 more source

Systemic Molecularly Targeted Therapies for Neoadjuvant and Salvage Craniopharyngioma: A Contemporary Narrative Review. [PDF]

Biomedicines
Neubecker JJ, Griepp DW, Turnbull JP, Caskey J, Desai S, Mansour A, Ahmed R, Beggs A, Griepp ATK, Heitkotter H, Claus CF, Richards BF, Kelkar PS.   +12 more
europepmc   +1 more source